Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute for Clinical Genetics, |
RCV003238473 | SCV002010010 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004040743 | SCV003624641 | uncertain significance | not specified | 2024-11-28 | criteria provided, single submitter | clinical testing | The c.828C>A (p.F276L) alteration is located in exon 8 (coding exon 8) of the SLC25A11 gene. This alteration results from a C to A substitution at nucleotide position 828, causing the phenylalanine (F) at amino acid position 276 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003238473 | SCV005729332 | uncertain significance | not provided | 2025-01-11 | criteria provided, single submitter | clinical testing | This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 276 of the SLC25A11 protein (p.Phe276Leu). This variant is present in population databases (rs147584261, gnomAD 0.09%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with SLC25A11-related conditions. ClinVar contains an entry for this variant (Variation ID: 1319152). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |